Pro: Use of Hepatitis C Virus–Positive Donors Should Be Considered Standard of Care
William A. Werbel, Christine M. Durand – 6 November 2018
Misconception: You Can’t Have Liver Disease With Normal Liver Chemistries
Zurabi Lominadze, Eric R. Kallwitz – 6 November 2018
Assessment and Management of Nutrition Status in the Hospitalized Patient With Cirrhosis
Christopher Moore, Adam C. Stein – 6 November 2018
Con: Use of Hepatitis C Virus–Positive Donors Should Be Restricted to Research Protocols
Grace S. Lee, Judith A. Anesi, Behdad D. Besharatian, Therese Bittermann, Stephanie Hamel, David S. Goldberg – 6 November 2018
At Diagnosis of Hepatocellular Carcinoma, African Americans With Hepatitis C Have Better Liver Function Than Other Patients
Adam C. Winters, Julie C. Sung, Brooke Wyatt, Deeva Berera, Thomas D. Schiano, Myron E. Schwartz, Ponni V. Perumalswami, Andrea D. Branch – 6 November 2018
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016
- Read more about Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016
Megan G. Hofmeister, Elizabeth M. Rosenthal, Laurie K. Barker, Eli S. Rosenberg, Meredith A. Barranco, Eric W. Hall, Brian R. Edlin, Jonathan Mermin, John W. Ward, A. Blythe Ryerson – 6 November 2018 – Hepatitis C virus (HCV) infection is the most commonly reported bloodborne infection in the United States, causing substantial morbidity and mortality and costing billions of dollars annually.
A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
Divya P. Kumar, Prasanna K. Santhekadur, Mulugeta Seneshaw, Faridoddin Mirshahi, Cora Uram‐Tuculescu, Arun J. Sanyal – 5 November 2018 – Hepatocellular carcinoma (HCC) is increasing as a cause of liver‐related mortality largely because of the growing burden of nonalcoholic steatohepatitis (NASH). The mechanisms of HCC development in nonalcoholic fatty liver disease (NAFLD) are incompletely understood. We initially identified apoptosis antagonizing transcription factor (AATF) to be associated with HCC in a mouse model of NASH that develops HCC without the addition of specific carcinogens.
Immunosuppression Minimization Trials in Liver Transplantation: Can We Predict Humoral Response to Assess Eligibility?
Magdalena Meszaros, Jose Ursic‐Bedoya, Stéphanie Faure, Georges‐Philippe Pageaux – 5 November 2018
Letter to the Editor: Confirmation of the Optimization to Prevent the First Esophageal Variceal Bleeding?
Xinwen Yan, Ziyuan Zou, Xun Li, Xiaolong Qi – 4 November 2018